{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T17:22:25Z","timestamp":1785691345727,"version":"3.56.0"},"reference-count":31,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,1,1]]},"abstract":"<jats:p>GCET1 (germinal center B cell\u2013expressed transcript-1) gene codes for a serpin expressed in germinal center (GC) B cells. Following the observation that follicular lymphoma cases exhibit an increased level of Gcet1 expression, compared with follicular hyperplasia, we have characterized Gcet1 protein expression in human tissues, cell lines, and a large series of lymphomas. To this end, we have performed immunohistochemical and Western blot analyses using a newly generated monoclonal antibody that is reactive in paraffin-embedded tissues. Our results demonstrate that Gcet1 is expressed exclusively by neoplasms hypothetically to be arrested at the GC stage of differentiation, including follicular lymphoma, nodular lymphocyte predominant Hodgkin lymphoma, and a subset of diffuse large B-cell lymphoma, T-cell\/histiocyte rich B-cell lymphoma, and Burkitt lymphoma. Within these tumors, Gcet-1 protein expression is restricted to a subset of GC B cells, establishing the existence of a distinct heterogeneity among normal and neoplastic GC B cells. None of the other B-cell lymphomas, that is, chronic lymphocytic leukemia, splenic marginal zone lymphoma, and mantle cell lymphoma, was Gcet1+, which underlines the potential utility of Gcet1 expression in lymphoma diagnosis. The results of RNA and protein expression should prompt further investigation into the role of Gcet1 in regulating B-cell survival.<\/jats:p>","DOI":"10.1182\/blood-2007-06-094151","type":"journal-article","created":{"date-parts":[[2007,9,27]],"date-time":"2007-09-27T01:14:26Z","timestamp":1190855666000},"page":"351-358","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":65,"title":["Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas"],"prefix":"10.1182","volume":"111","author":[{"given":"Santiago","family":"Montes-Moreno","sequence":"first","affiliation":[{"name":"Lymphoma Group, Spanish National Cancer Centre (CNIO), Madrid, Spain;"},{"name":"Department of Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Roncador","sequence":"additional","affiliation":[{"name":"Monoclonal Antibody Unit,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Maestre","sequence":"additional","affiliation":[{"name":"Monoclonal Antibody Unit,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerea","family":"Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Lymphoma Group, Spanish National Cancer Centre (CNIO), Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Sanchez-Verde","sequence":"additional","affiliation":[{"name":"Histology and Immunohistochemistry Unit, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca I.","family":"Camacho","sequence":"additional","affiliation":[{"name":"Lymphoma Group, Spanish National Cancer Centre (CNIO), Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimena","family":"Cannata","sequence":"additional","affiliation":[{"name":"Lymphoma Group, Spanish National Cancer Centre (CNIO), Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge L.","family":"Martinez-Torrecuadrada","sequence":"additional","affiliation":[{"name":"Protein Technology Unit, CNIO, Madrid, Spain; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulei","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing C.","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Piris","sequence":"additional","affiliation":[{"name":"Lymphoma Group, Spanish National Cancer Centre (CNIO), Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111823100871600_B1","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1002\/1521-4141(200010)30:10<3039::AID-IMMU3039>3.0.CO;2-H","article-title":"Identification of centerin: a novel human germinal center B cell-restricted serpin.","volume":"30","author":"Frazer","year":"2000","journal-title":"Eur J Immunol"},{"key":"2019111823100871600_B2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0002-9440(10)63637-1","article-title":"Two newly characterized germinal center B-cell-associated genes, GCET1 and GCET2, have differential expression in normal and neoplastic B cells.","volume":"163","author":"Pan","year":"2003","journal-title":"Am J Pathol"},{"key":"2019111823100871600_B3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1042\/BJ20070174","article-title":"Molecular characterisation of centerin, a germinal centre cell serpin.","volume":"405","author":"Paterson","year":"2007","journal-title":"Biochem J"},{"key":"2019111823100871600_B4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"2019111823100871600_B5","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med"},{"key":"2019111823100871600_B6","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/S0002-9440(10)64459-8","article-title":"Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma.","volume":"161","author":"Tracey","year":"2002","journal-title":"Am J Pathol"},{"key":"2019111823100871600_B7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1089\/107999004322917034","article-title":"Transcriptional response of T cells to IFN-alpha: changes induced in IFN-alpha-sensitive and resistant cutaneous T cell lymphoma.","volume":"24","author":"Tracey","year":"2004","journal-title":"J Interferon Cytokine Res"},{"key":"2019111823100871600_B8","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1182\/blood-2002-11-3574","article-title":"Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study.","volume":"102","author":"Tracey","year":"2003","journal-title":"Blood"},{"key":"2019111823100871600_B9","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1038\/sj.leu.2403960","article-title":"Differential expression of NF-kappaB pathway genes among peripheral T-cell lymphomas.","volume":"19","author":"Martinez-Delgado","year":"2005","journal-title":"Leukemia"},{"key":"2019111823100871600_B10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/path.1768","article-title":"Expression of the NF-kappaB targets BCL2 and BIRC5\/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.","volume":"206","author":"Tracey","year":"2005","journal-title":"J Pathol"},{"key":"2019111823100871600_B11","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1182\/blood-2004-10-3898","article-title":"Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis.","volume":"106","author":"Ruiz-Ballesteros","year":"2005","journal-title":"Blood"},{"key":"2019111823100871600_B12","first-page":"467","article-title":"PRDM1\/BLIMP-1 expression in multiple B and T-cell lymphoma.","volume":"91","author":"Garcia","year":"2006","journal-title":"Haematologica"},{"key":"2019111823100871600_B13","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/hmg\/10.7.657","article-title":"Tissue microarray technology for high-throughput molecular profiling of cancer.","volume":"10","author":"Kallioniemi","year":"2001","journal-title":"Hum Mol Genet"},{"key":"2019111823100871600_B14","volume-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"Jaffe","year":"2001"},{"key":"2019111823100871600_B15","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/01.pas.0000128671.92609.af","article-title":"Aberrant Bcl6 protein expression in mantle cell lymphoma.","volume":"28","author":"Camacho","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"2019111823100871600_B16","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0002-9440(10)63150-1","article-title":"Building an outcome predictor model for diffuse large B-cell lymphoma.","volume":"164","author":"S\u00e1ez","year":"2004","journal-title":"Am J Pathol"},{"key":"2019111823100871600_B17","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1182\/blood-2003-03-0692","article-title":"Phenotype and genotype of interfollicular large B cells, a subpopulation of lymphocytes often with dendritic morphology.","volume":"102","author":"Marafioti","year":"2003","journal-title":"Blood"},{"key":"2019111823100871600_B18","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00000372-200406000-00015","article-title":"Immunofluorescent and FISH analysis of skin biopsies.","volume":"26","author":"Gellrich","year":"2004","journal-title":"Am J Dermatopathol"},{"key":"2019111823100871600_B19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"2019111823100871600_B20","doi-asserted-by":"crossref","first-page":"30007","DOI":"10.1074\/jbc.270.50.30007","article-title":"Role of the catalytic serine in the interactions of serine proteinases with protein inhibitors of the serpin family: contribution of a covalent interaction to the binding energy of serpin-proteinase complexes.","volume":"270","author":"Olson","year":"1995","journal-title":"J Biol Chem"},{"key":"2019111823100871600_B21","doi-asserted-by":"crossref","first-page":"27802","DOI":"10.1074\/jbc.271.44.27802","article-title":"A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier A is present in cytotoxic lymphocytes.","volume":"271","author":"Sun","year":"1996","journal-title":"J Biol Chem"},{"key":"2019111823100871600_B22","doi-asserted-by":"crossref","first-page":"7797","DOI":"10.1074\/jbc.272.12.7797","article-title":"Target protease specificity of the viral serpin CrmA: analysis of five caspases.","volume":"272","author":"Zhou","year":"1997","journal-title":"J Biol Chem"},{"key":"2019111823100871600_B23","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0046-8177(99)90003-5","article-title":"Clinical significance of follicular lymphoma with monocytoid B cells: Non-Hodgkin's Lymphoma Classification Project.","volume":"30","author":"Nathwani","year":"1999","journal-title":"Hum Pathol"},{"key":"2019111823100871600_B24","doi-asserted-by":"crossref","first-page":"10209","DOI":"10.1073\/pnas.180316097","article-title":"Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas.","volume":"97","author":"Lossos","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111823100871600_B25","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1182\/blood-2005-01-0168","article-title":"Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas.","volume":"106","author":"Bellan","year":"2005","journal-title":"Blood"},{"key":"2019111823100871600_B26","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1182\/blood-2002-06-1931","article-title":"HGAL is a novel interleukin-4-inducible gene that strongly predicts survival in diffuse large B-cell lymphoma.","volume":"101","author":"Lossos","year":"2003","journal-title":"Blood"},{"key":"2019111823100871600_B27","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1182\/blood.V93.8.2679","article-title":"Molecular analysis of single B cells from T-cell-rich B-cell lymphoma shows the derivation of the tumor cells from mutating germinal center B cells and exemplifies means by which immunoglobulin genes are modified in germinal center B cells.","volume":"93","author":"Br\u00e4uninger","year":"1999","journal-title":"Blood"},{"key":"2019111823100871600_B28","doi-asserted-by":"crossref","first-page":"9337","DOI":"10.1073\/pnas.94.17.9337","article-title":"Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells.","volume":"94","author":"Braeuninger","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111823100871600_B29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00000478-199201000-00006","article-title":"Histiocyte-rich B-cell lymphoma: a distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.","volume":"16","author":"Delabie","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"2019111823100871600_B30","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1182\/blood-2004-08-3112","article-title":"Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation.","volume":"105","author":"Natkunam","year":"2005","journal-title":"Blood"},{"issue":"1","key":"2019111823100871600_B31","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1182\/blood-2006-04-014977","article-title":"Expression of the human germinal center associated lymphoma (HGAL) protein identifies a subset of classical Hodgkin Lymphoma of germinal center derivation and improved survival.","volume":"109","author":"Natkunam","year":"2007","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/111\/1\/351\/1219413\/zh800108000351.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/111\/1\/351\/1219413\/zh800108000351.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T04:10:32Z","timestamp":1574136632000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/111\/1\/351\/107894\/Gcet1-centerin-a-highly-restricted-marker-for-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2007-06-094151","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,1]]}}}